Central Trust Company’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.05K | Hold |
|
|||||
|
2025
Q2 | $4.53K | Sell |
|
|||||
|
2025
Q1 | $8.41K | Sell |
|
|||||
|
2024
Q4 | $11.7K | Buy |
|
|||||
|
2024
Q3 | $8.76K | Hold |
|
|||||
|
2024
Q2 | $10.5K | Hold |
|
|||||
|
2024
Q1 | $10.5K | Hold |
|
|||||
|
2023
Q4 | $10K | Sell |
|
|||||
|
2023
Q3 | $15.3K | Buy |
|
|||||
|
2023
Q2 | $9.43K | Sell |
|
|||||
|
2023
Q1 | $34.9K | Sell |
|
|||||
|
2022
Q4 | $48.6K | Sell |
|
|||||
|
2022
Q3 | $45K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $31K | Hold |
|
|||||
|
2020
Q1 | $22K | Hold |
|
|||||
|
2019
Q4 | $27K | Hold |
|
|||||
|
2019
Q3 | $23K | Buy |
|